|
Hey there, EMDR is everywhere all of a sudden. Have you noticed? BLS audio tracks on meditation apps, tappers you can buy on Amazon, and apps walking clients through "EMDR exercises" between sessions. Even AI tools are now claiming to guide people through reprocessing at home. Some of this is really good news. However, some of it deserves a healthy dose of skepticism. Let me start with the good news. The growing interest in EMDR is validating. For me, at least. For a long time, EMDR sat on the fringes of mainstream psychotherapy while skeptics wrote it off as pseudoscience. Insurance panels dragged their feet, and a lot of training programs didn't even mention it (while the ones that did often treated it as more of an “oddity” than a serious modality for resolution of trauma and all kinds of related conditions). But EMDR is recognized by the WHO, APA, VA, and DoD as a frontline evidence-based treatment for PTSD.There are hundreds of studies backing it up, referrals from psychiatrists and primary care physicians are increasing, and clients are showing up to intake appointments already asking for EMDR by name. This also means more research funding, and more importantly, more people who need trauma treatment have a shot at getting it. Here's where the caution comes in. When a clinical methodology proves this effective, people try to productize it. Once a modality gains legitimacy, companies show up looking for ways to package it, scale it, automate it, or bundle it into something they can sell without the friction of a licensed clinician. In other words, “skipping the therapist” for the sake of scalability and profit margins. What these products confuse is the mechanism vs. the environment. A pair of vibrating tappers or an audio track isn't EMDR. Bilateral stimulation is simply a tactile or auditory stimulus; it is not reprocessing. Reprocessing requires a trained clinician knowing the client, confirming their stabilization capacity and window of tolerance, tracking somatic shifts, noticing when a client drops out of their window of tolerance, navigating defenses, offering cognitive interweaves backed by years of clinical development, and holding a regulated container when implicit memories surface. When a self-directed tool attempts to bypass Phase 1 and Phase 2 to jump straight into reprocessing, it strips out the clinical judgment that keeps the work safe and effective. It also can’t comprehend the very important non-verbal, in the moment, human context. At best, these tools offer temporary distress reduction. On the other hand, they can also trigger uncontained activation in an isolated client who doesn't have the internal resourcing or the therapeutic presence to land safely. There are real safety and ethical risks involved. The growth itself of EMDR is worth celebrating, but it also means we need to be crystal clear (with our clients and referring providers) about what EMDR is. And the best way, in my clinical opinion, is to stay consistent in our core message: EMDR is a comprehensive clinical framework. It’s not a gadget. EMDR requires an attuned, trained clinician tracking the client's nervous system to navigate blockages and keep the work grounded. The tools that support that process, BLS included, are only instruments inside the therapeutic container. We’re going to have to repeat that message a lot over the next few years. The products aren't going away, and the marketing behind them is only going to get more sophisticated. Have you noticed clients showing up already having tried some "EMDR" product? How are you talking with them about the difference? Hit reply and let me know how you’ve been handling it. Until next time, Chris Thanks for reading Helicon's EMDR Therapist Weekly, where we aim to provide a weekly dose of insights, tools, and opportunities for EMDR therapists; designed to support your growth, sharpen your practice, and connect you with what's next. If you're not already subscribed, subscribe here. You can also click here to learn about what Helicon is building, or sign up to be notified when the platform is publicly available, if you're an EMDR provider and want to connect with others on the same path. Disclaimer: The information contained in this article is for informational purposes only. This is not legal or clinical advice and we make no guarantees about the outcomes or results from information shared in this document. Proceed at your own risk and discretion. |
A weekly dose of insights, tools, and opportunities for EMDR therapists; designed to support your growth, sharpen your practice, and connect you with what's next.
Hey there, Has a client ever told you they're microdosing? Or that they're planning a psilocybin retreat, or starting ketamine treatment? Psychedelic use is coming up a lot more often during sessions, leaving many EMDR therapists unsure of their role. We're not prescribing or providing these substances, but clients are using them anyway and bringing those experiences back into our offices. That’s why this week, I wanted to look at what the research says about macro-doses and micro-doses, and...
Hey there, Have you ever had someone tell you EMDR is “pseudoscience”? Maybe it was a colleague in case consultation, or a professor back in grad school. Or maybe it was a client who read something online the night before their first session, worried they were signing up for something that doesn't work. How did it make you feel? Defensive? There are a number of criticisms that come up again and again, and some of them have a grain of truth. So this week I want to walk through the most common...
Hey there, In case you missed it, we recently sent out the first invitations to join Helicon. What’s Helicon? In short, it’s a platform built specifically for EMDR therapists. Members can search our private consultant directory, track consultation hours alongside their consultant, find guides and partner discounts, access private virtual events with subject matter experts, and connect with other EMDR therapists in our private Signal group. Now that the first invites have gone out, I wanted to...